Telix Pharma Bets Up To $2.3B For ITM In Radiopharma Push
Telix Pharmaceuticals Ltd. on Monday unveiled plans to acquire ITM Isotope Technologies Munich SE in a deal worth up to $2.3 billion that was built by three law firms....To view the full article, register now.
Already a subscriber? Click here to view full article